Capital raised by PIPr Therapeutics
1 Form D filing · first filed Oct 2025 · Durham, NC
By POA from Heather Madsen, CEO
Signatory on PIPr Therapeutics's Form D filings · $1.5M raised across 1
Tyler Dove is on file as By POA from Heather Madsen, CEO at PIPr Therapeutics in Durham, NC. PIPr Therapeutics has 1 Form D filing on record, $1.5M raised in total. Tyler Dove appears as a signatory on the company's filings.
The company's stated scientific focus: preclinical therapeutic programs built on precise inhibition of metalloprotease targets. No named drug candidates, modalities, or indications have been disclosed publicly.
